Kelly Ryan R, McDonald Lindsay T, Jensen Nathaniel R, Sidles Sara J, LaRue Amanda C
Research Services, Ralph H. Johnson VA Medical Center, Charleston, SC, United States.
Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC, United States.
Front Psychiatry. 2019 Apr 9;10:200. doi: 10.3389/fpsyt.2019.00200. eCollection 2019.
The significant biochemical and physiological effects of psychological stress are beginning to be recognized as exacerbating common diseases, including osteoporosis. This review discusses the current evidence for psychological stress-associated mental health disorders as risk factors for osteoporosis, the mechanisms that may link these conditions, and potential implications for treatment. Traditional, alternative, and adjunctive therapies are discussed. This review is not intended to provide therapeutic recommendations, but, rather, the goal of this review is to delineate potential interactions of psychological stress and osteoporosis and to highlight potential multi-system implications of pharmacological interventions. Review of the current literature identifies several potentially overlapping mechanistic pathways that may be of interest (e.g., glucocorticoid signaling, insulin-like growth factor signaling, serotonin signaling) for further basic and clinical research. Current literature also supports the potential for cross-effects of therapeutics for osteoporosis and mental health disorders. While studies examining a direct link between osteoporosis and chronic psychological stress are limited, the studies reviewed herein suggest that a multi-factorial, personalized approach should be considered for improved patient outcomes in populations experiencing psychological stress, particularly those at high-risk for development of osteoporosis.
心理压力显著的生化和生理效应开始被认为会加剧包括骨质疏松症在内的常见疾病。本综述讨论了与心理压力相关的心理健康障碍作为骨质疏松症风险因素的现有证据、可能联系这些病症的机制以及对治疗的潜在影响。文中讨论了传统、替代和辅助疗法。本综述并非旨在提供治疗建议,相反,本综述的目的是描绘心理压力与骨质疏松症之间的潜在相互作用,并强调药物干预可能对多系统产生的影响。对当前文献的综述确定了几个可能值得进一步基础和临床研究关注的潜在重叠机制途径(例如,糖皮质激素信号传导、胰岛素样生长因子信号传导、血清素信号传导)。当前文献也支持治疗骨质疏松症和心理健康障碍的药物存在交叉效应的可能性。虽然研究骨质疏松症与慢性心理压力之间直接联系的研究有限,但本文综述的研究表明,对于经历心理压力的人群,尤其是那些骨质疏松症高危人群,应考虑采用多因素、个性化的方法以改善患者预后。